Vimarsana
Biggest News Aggregation in the World

Page 2 - Original Note News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Original Note. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Original Note Today - Breaking & Trending Today

NaaS Technology : CONVERTIBLE NOTE PURCHASE AGREEMENT NAAS TECHNOLOGY INC. LMR MULTI-STRATEGY MASTER FUND LIMITED - Vimarsana News

NaaS Technology : CONVERTIBLE NOTE PURCHASE AGREEMENT NAAS TECHNOLOGY INC. LMR MULTI-STRATEGY MASTER FUND LIMITED

CONVERTIBLE NOTE PURCHASE AGREEMENT by and among NAAS TECHNOLOGY INC. and LMR MULTI-STRATEGY...

HEXO : Notice of Special Meeting of Shareholders and Management Information Circular of the registrant dated May 10, 2023 - Form 6-K - Vimarsana News

HEXO : Notice of Special Meeting of Shareholders and Management Information Circular of the registrant dated May 10, 2023 - Form 6-K

The matters set forth herein have not been approved by any securities regulatory authority, nor has any securities regulatory authority passed upon the fairness or merits of the... | May 15, 2023

MULN Stock Alert: Mullen Just Eliminated $13 Million of Debt - Vimarsana News

MULN Stock Alert: Mullen Just Eliminated $13 Million of Debt

Mullen has successfully eliminated $13 million of debt, likely through the conversion of Esousa's convertible promissory notes.

HEXO Reports Q4'22 and FY22 Financial Results | U.S. - Vimarsana News

HEXO Reports Q4'22 and FY22 Financial Results | U.S.

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7,

Statera BioPharma, Inc.: Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF - Vimarsana News

Statera BioPharma, Inc.: Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF

FORT COLLINS, CO / ACCESSWIRE / October 21, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that